Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:87f2d71678a14732bc74e04f815a25a6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:87f2d71678a14732bc74e04f815a25a62021-12-02T15:35:34ZInjectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction10.1038/s41467-019-12748-82041-1723https://doaj.org/article/87f2d71678a14732bc74e04f815a25a62019-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12748-8https://doaj.org/toc/2041-1723Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.Sarah McLaughlinBrian McNeillJames PodrebaracKatsuhiro HosoyamaVeronika SedlakovaGregory CronDavid SmythRichard SeymourKeshav GoelWenbin LiangKatey J. RaynerMarc RuelErik J. SuuronenEmilio I. AlarconNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-14 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Sarah McLaughlin Brian McNeill James Podrebarac Katsuhiro Hosoyama Veronika Sedlakova Gregory Cron David Smyth Richard Seymour Keshav Goel Wenbin Liang Katey J. Rayner Marc Ruel Erik J. Suuronen Emilio I. Alarcon Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
description |
Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium. |
format |
article |
author |
Sarah McLaughlin Brian McNeill James Podrebarac Katsuhiro Hosoyama Veronika Sedlakova Gregory Cron David Smyth Richard Seymour Keshav Goel Wenbin Liang Katey J. Rayner Marc Ruel Erik J. Suuronen Emilio I. Alarcon |
author_facet |
Sarah McLaughlin Brian McNeill James Podrebarac Katsuhiro Hosoyama Veronika Sedlakova Gregory Cron David Smyth Richard Seymour Keshav Goel Wenbin Liang Katey J. Rayner Marc Ruel Erik J. Suuronen Emilio I. Alarcon |
author_sort |
Sarah McLaughlin |
title |
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
title_short |
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
title_full |
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
title_fullStr |
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
title_full_unstemmed |
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
title_sort |
injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6 |
work_keys_str_mv |
AT sarahmclaughlin injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT brianmcneill injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT jamespodrebarac injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT katsuhirohosoyama injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT veronikasedlakova injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT gregorycron injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT davidsmyth injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT richardseymour injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT keshavgoel injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT wenbinliang injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT kateyjrayner injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT marcruel injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT erikjsuuronen injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction AT emilioialarcon injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction |
_version_ |
1718386545367449600 |